PharmAus19 will take place at Parliament House, Canberra, ACT on Tuesday 15 October.
Registration will be opening from 9:00am for a 9:30am start.
To enter the Policy Symposium, please arrive at the public entrance, proceed through the security bag check and then make your way to the Theatre located on Level 1.
SESSION 1: Medicines matter to the consumer - Who is the empowered consumer? What do consumers want from a universal health care system and from the industry that provides medical and technological solutions?
SESSION 2: Medicines Matter to the community - The greatest good for the greatest number of people at the lowest cost, versus “personalised healthcare” where the treatment may be based on an individual genetic profile. How does the community engage in advocacy for treatments that may treat a minority of patients but the benefits are far reaching/permanent. What about ethical dilemmas?
SESSION 3: Medicines Matter to the economy - Professor Frank Lichtenberg talks about the impact medical intervention can have on the economy and will provide an exciting update on his 2015 research.
SESSION 4: Medicines Matter to the government – During assessment, we talk about the value of medicines. What other value metrics could the government include in their assessments.
INNOVATIVE MEDICINES SHOWCASE
Medicines Australia member companies and other key partners will come together in the Mural Hall for exciting, interactive and educational displays providing parliamentarians with an opportunity to learn more about our sector. Each of these displays will highlight the role the industry plays in Australia, with particular reference to the patient, the community and the economy.
The third annual Leaders Breakfast for Managing Directors and Health Consumer Organisations will take place on Wednesday 16 October at the National Press Club.
Dr Dana Bradford will be providing a keynote address at the breakfast. Dr Bradford is a senior research scientist with the Australian eHealth Research Centre in CSIRO, and an adjunct senior research fellow with QBI. Her project work with CSIRO has predominantly centred on digital services for equitable healthcare. Dana is also involved in projects to facilitate the integration of genomic medicine into every day care and technology for young adults on the autism spectrum.